Podcasts about msci china

S&P futures are pointing to a slightly lower open today, down (0.23%). European equity markets are higher in early trading, following a positive close on Monday, while Asian equities advanced broadly, led by China's tech sector. Foreign portfolio inflows into mainland China securities hit a record $228.1B in February. Net flows, including outbound investments, turned positive for the first time since September. The MSCI China index is up +23% YTD, contrasting with a (3.5%) decline in the S&P 500. Foreign holdings of Chinese government bonds also rose for the first time in six months, reflecting renewed investor interest.Companies Mentioned: Google, Walgreen, Americold Realty Trust, BYD, NIO, CATL

China – Aufstrebende Supermacht oder wackeliger Riese? Tobias Kramer und Christian W. Röhl analysieren in der neuesten echtgeld.tv-Folge die jüngsten Entwicklungen rund um den chinesischen Aktienmarkt, wobei Christian erstmals in seiner neuen Rolle als Chief Economist von Scalable Capital vor der Kamera steht. Zunächst geht es um Chinas Weg von einer schwer zugänglichen Börse hin zu einem wichtigen Investmentstandort, inklusive einer Betrachtung des MSCI China All Shares Index und einem passenden ETF auf diesen. Danach nehmen sie drei chinesische Aktien-Giganten unter die Lupe: Tencent, Alibaba und BYD. Tencent ist der Tech-Gigant mit einem breiten Portfolio aus Gaming und FinTech. Alibaba steht im Zeichen des Wandels und kämpft um frischen Schwung in den Bereichen E-Commerce und Cloud. Und BYD? Der Elektroauto-Riese setzt die etablierten Automobilhersteller, besonders die deutschen, mit seiner Innovationskraft mächtig unter Druck. Welche Chancen und Risiken bergen diese drei Unternehmen? Wie schneidet China im Vergleich zu anderen Schwellenländern ab? Und wie beeinflussen geopolitische Spannungen die Aktienmärkte? All das und mehr erfahrt ihr in dieser Folge! Diskutiert mit uns in den Kommentaren: Setzt ihr auf China als Investment oder seht ihr mehr Risiken als Chancen?

S&P futures are pointing to a flat open today, down (0.02%). In Asia, Greater China markets recorded historical gains, with the Shanghai Composite up +8%, while Japan's Nikkei 225 plummeted close to (5%) . European equity markets are broadly lower in early trades. Chinese stocks have rallied for nine consecutive days as the CSI 300 surged +8.5%, its largest jump since 2008. Having lost over (45%) from its 2021 peak, the index has rebounded over +20%. Despite the rally, the MSCI China forward P/E remains at 10.8x. UBS has increased its target for MSCI China to $70. Morgan Stanley predicts an additional +10% upside for the CSI 300. HSBC notes that new measures from China's central bank may boost corporate buybacks. Companies Mentioned: TPG, Boeing, OpenAI, Devon Energy

Quelle semaine ! Les marchés boursiers ont reçu le concours qu'ils n'attendaient plus, celui de la Chine. Les mesures de relance annoncées par Pékin ont renforcé l'enthousiasme d'investisseurs déjà prêts à prendre des risques. Du pain béni pour les valeurs du luxe, qui sortent momentanément de leur dépression. A Wall Street, les records s'empilent. Tous les compteurs sont tellement au vert que des gens vont commencer à se demander d'où va arriver la mauvaise nouvelle.

Louisa Fok, China Equity Strategist, Bank of Singapore discusses how investors should approach Chinese markets, as President Xi Jinping gets ready to lay out his vision for the economy post-Plenum. Following a rise of 4% in the MSCI China in 1H2024, she outlines some of the supportive factors for some sectors, especially Internet and platform companies. We also examine how much of headwinds trade tensions and tariffs may pose in the coming months. Produced/Presented: Ryan HuangSee omnystudio.com/listener for privacy information.

Singapore equities began trading in positive territory today, as US investors awaited crucial payrolls data and mull the European Central Bank's move to cut lending rates.  The Straits Times Index (STI) opened 0.2 per cent higher at 3,336.22 points after 27.7 million securities changed hands in the broader market. In terms of companies to watch today, we have Shanghai-based electric vehicle (EV) maker Nio, after its adjusted net loss widened by 18.1 per cent to 4.9 billion yuan (S$911.7 million) in the first fiscal quarter. Elsewhere, from more on the European Central Bank's first rate cut in five years to Boeing's departing CEO set to testify before the US Senate on issues surrounding the planemaker's safety crisis, more international and corporate headlines remain in focus. On Market View, The Evening Runway's finance presenter Chua Tian Tian unpacked the developments with Too Jun Cheong, Assistant Dealing Manager from Moomoo Singapore.See omnystudio.com/listener for privacy information.

Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy After a terrible spell between Jan '23 and January of this year, where MSCI China lost almost 40%, it is now up 25% from the lows. While we do not believe that the longer term structural concerns of deflationary backdrop, real estate demand-supply imbalances, credit saturation and global decoupling are finished, our tactical view remains that the more positive China trading could last through summer, through July-August, until the US elections heat up in earnest. There is still an EM investor underweight on China, and the valuations probably have another 10-15% upside before closing the discount to historical. A more bullish tactical China stance was one of the drivers of our upgrade of Eurozone equities in Q1. We continue to believe that Eurozone risk-reward has improved, and that the region will at least hold its own vs the US, whether the overall market goes up or down. UK (OW) is also starting to trade better of late, erasing the almost 10% relative weakness seen earlier in the year. At sector level, we think commodities remain interesting as a way to position for more positive China trading, both Mining and Energy. We are less positive on some of other traditional China plays, such as Autos (UW) and Luxury (N). Pricing is a significant risk for both, as well as a potential volume disappointment, leaving their elevated margins at risk. More broadly, at sector level we have been arguing that Defensives should start to trade better, last month Real Estate, Utilities, Staples and Healthcare are top 4 sectors in Europe. Now, more positive tactical China call is clearly a big help for EM group, but we do not believe EM is a buy vs DM. The headwinds for EM remain Fed higher for longer, and stronger USD. EM equities typically struggle to outperform DM when their currencies are under pressure. This podcast was recorded on 12 May 2024. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4696703-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party.

Wer entscheidet die Vorherrschaft in der Autobranche um sich und wer ist der beste Autobauer? Gerade die deutschen Autobauer haben gerade zu kämpfen wie das Beispiel Volkswagen in China zeigt. Die neuen Modelle kommen nicht an und man bekommt bei den E-Autos fast kein Bein auf den Boden. Besser macht es da schon BYD: Der chinesische Autobauer dominiert den Markt und ist dabei profitabel. Lohnt sich der Einstieg bei der BYD Aktie? Mario ist investiert und verrät dir, warum er sich für die Aktie begeistert. Natürlich müssen sich Anleger der Risiken in China bewusst sein. Auch wenn man nur über ETFs investieren will in China, gibt es einiges zu beachten. Ist China gerade eine Riesenchance für Anleger? Wir sprechen in diesem Video über Chancen und Risiken und welche Aktien in Indizes wie dem CSI 300, dem Hang Seng oder dem MSCI China enthalten sind. Zuletzt haben chinesische Tech-Werte bereits angezogen wie die Tencent Aktie, die Alibaba Aktie und auch die Xiaomi Aktie macht Schlagzeilen, weil man nun auch ein Auto vorgestellt hat. Zudem liefert Tesla gerade positive Schlagzeilen. Elon Musk machte einen überraschenden Besuch in Peking und will das Full Self Driving (FSD) im Reich der Mitte vorantreiben. Es sieht gerade gut aus und die Tesla-Aktie schießt weiter nach oben nach der Durststrecke zuletzt

Speaker: Mislav Matejka, CFA - Head of Global Equity Strategy From a global equity perspective, we had upgraded Japan to OW in Dec '22. While we still think that USD is likely to be stronger from here, it might not be crucial to hedge JPY anymore, as the interest rate differential between the US and Japan looks set to start converging this year. For the continued bullish view on Japan, we reiterate: First, TSE reform is set to lead to improved corporate profitability and greater shareholder returns, given that more than half of Japanese stocks are still trading net cash, and 40% are trading below tangible book. Second, even though it feels as though Japan is a consensus overweight, we think that flows are still at an early stage. Foreigners bought 5trn Yen of Japanese stocks in 2023, which compares to 35trn Yen during the Koizumi era and 25trn Yen during Abenomics, the last two times when Japanese stocks moved up more than 100%. Third, there is a case to be made for some reflation in Japan, through house price appreciation and positive wage growth for Japanese consumers, and lastly, Japan is the only large DM market with dividend yield above bond yield, vs historical. In a European context, after outperforming strongly in 2022, the only large DM market up in that year, the UK lagged significantly in 2023. This has left UK at record cheap, even ex US. UK has the highest dividend yield out of all markets, at 4.3% yield, vs 2.0% for MSCI World. With the central bank cutting cycle about to commence, dividend strategies might come into the spotlight. The UK is a commodity-heavy market, and both Materials and Energy lagged last year, dragging the index down. If commodities find a floor, especially as the FCF yields of both Mining and Energy are very high at present, this could help. China outlook could play a role, too. We held a cautious fundamental view on the China market for a while, but recognize that it is heavily underowned and cheap post the big selloff: MSCI China lost 30% in a year. If China sees short squeezes, that could indirectly benefit the UK.   This podcast was recorded on 12 February 2024. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4622327-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party.

Original Release on December 7th, 2023: Will India equities continue to outperform China equities in 2024? The two key factors investors should track.----- Transcript -----Welcome to Thoughts on the market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'm going to be discussing our continued preference for Indian equities versus China equities. It's Thursday, December 7th at 9 a.m. in Singapore. MSCI India is tracking towards a third straight year of outperformance of MSCI China, and India is currently our number one pick. Indeed, we're running our largest overweight at 100 basis points versus benchmark. In contrast, we reduced China back to equal weight in the summer of this year. So going into 2024, we're currently anticipating a fourth straight year of India outperformance versus China. Central to our bullish view on India versus China, is the trend in earnings. Starting in early 2021, MSCI India earnings per share in US dollar terms has grown by 61% versus a decline of 18% for MSCI China. As a result, Indian earnings have powered ahead on a relative basis, and this is the best period for India earnings relative to China in the modern history of the two equity markets. There are two fundamental factors underpinning this trend in India's favor, both of which we expect to continue to be present in 2024. The first is India's relative economic growth, particularly in nominal GDP terms. Our economists have written frequently in recent months on China's persistent 3D challenges, that is its battle with debt, deflation and demographics. And they're forecasting another subdued year of around 5% nominal GDP growth in 2024. In contrast, their thesis on India's decade suggests nominal GDP growth will be well into double digits as both aggregate demand and crucially supply move ahead on multiple fronts. The second factor is currency stability. Our FX team anticipate that for India, prudent macro management, particularly on the fiscal deficit, geopolitical dynamics and inward multinational investment, can lead to continued Rupee stability in real effective terms versus volatility in previous cycles. For the Chinese Yuan, in contrast, the real effective exchange rates has begun to slide lower as foreign direct investment flows have turned negative for the first time and domestic capital flight begins to pick up. Push backs we get on continuing to prefer India to China in 2024, are firstly around potential volatility of the Indian markets in an election year. But secondly, a bigger concern is relative valuations. Now, as always, we feel it's important to contextualize valuations versus return on equity and return on equity trajectory. Currently, India is trading a little over 3.7x price to book for around 15% ROE. This means it has one of the highest ROE's in emerging markets, but is the most expensive market. And in price to book terms, second only to the US globally. China is trading on a much lower price to book of 1.3x, but its ROE is 10% and indeed on an ROE adjusted basis, it's not particularly cheap versus other emerging markets such as Korea or South Africa. Importantly for India, we expect ROE to remain high as earnings compound going forward, and corporate leverage can build from current levels as nominal and real interest rates remain low to history. So the outlook is positive. But for China, the outlook is very different. And in a recent detailed piece, drawing on sector inputs from our bottom up colleagues, we concluded that whilst the base case would be for ROE stabilization, if reflation is successful, there's also a bear case for ROE to fall further to around 7% over the medium term, or less than half that of India today. Finally, within the two markets we're overweight India, financials, consumer discretionary and industrials. And these are sectors which typically do best in a strong underlying growth environment. They're the same sectors on which we're cautious in China. There our focus is on A-shares rather than large cap index names, and we like niche technology, hardware and clean energy plays which benefit from China's policy objectives. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

China continues to face the triple challenge of debt, deflation and demographics. But are investors missing an opportunity in China equities? ----- Transcript -----Laura Wang:] Welcome to Thoughts on the Market. I'm Laura Wang, Morgan Stanley's Chief China Equity Strategist. Robin Xing: And I'm Robin Xing, Morgan Stanley's Chief China Economist. Laura Wang: On this special episode of the podcast, we'll discuss our 2024 outlook for China's economy and equity market and what investors should focus on next year. It's Tuesday, December 12th, 9 a.m. in Hong Kong. Laura Wang: Robin, China's post reopening recovery has been lackluster in 2023, disappointing expectations. We've seen significant challenges in housing and local government financing vehicles, which are pressuring the Chinese economy to the verge of a debt deflation loop. Can you explain some of these current dynamics? Robin Xing: China is in this difficult battle against the it's 3D problems, namely debt, deflation and demographics. China has stepped up reflationary measures since the July Politburo meeting, including immediate budgetary expansion, kick start of local government debt resolution and easing on the housing sector. Growth also bottomed out from its second quarter trough. That said, the reflationary journey remains gradual and bumpy. In particular, the downturn in the housing sector and its spillover to local government are still lingering. And it might take some time until it converges to a new steady state. Against this backdrop, we expect China to continue to roll out stronger and more coordinated fiscal, monetary and housing easing policies. Laura Wang: What measures does China need to undertake to avoid a debt deflation loop? Robin Xing: Well, there is no easy way out. We think China needs a systematic macro solution, including both cyclical stimulus and structural reforms, to decisively fend off a debt deflation loop. In particular, we proposed a 5R action plan. Reflation, Rebalance, Restructuring, Reform and Rekindle. So that includes reflecting the economy with policy stimulus to support aggregate demand. Rebalancing the economy towards consumption with structural initiatives such as fiscal transfer to the households. Restructuring balance sheets of troubled sectors, including property and financing league of Local Government. Reforming the SOE's of the public sector and rekindle the private sectors animal spirit. So far, Beijing has only completed 25% of the 5R strategy, led by some stimulus in reflation sector and also restructuring its local debt. We expect the progress to reach 50% by end 2024, and China could lead to this debt deflation loop in about two years after 2025. Laura Wang: Debt and deflation are 2 of the 3D's in what you call China's 3D journey. Demographics is the third challenge on this list. Why are demographics an economic headwind and how is China handling this challenge now? Robin Xing: Well, Laura, there is a little dispute on China's aging population. This will diminish capital returns and drag growth. So in our long term growth forecast, labor quantity will lower overall GDP growth by 40 basis points every year between 2025 to 2030. Though the declining labor quantity is unlikely to be reversed, Beijing would make more efforts in better utilizing higher labor quality, which has been increasing steadily. On that front, Beijing could step up reviving private sector confidence, which will bring more jobs and translate to labor with higher education into stronger output. Detailed measures could include, they start to issue the financial license to FinTech and resumption of offshore IPO by firms with sensitive data. That could send a clearer message to the end of regulatory reset since 2021. Laura Wang: With all these macro backdrops, what are your expectations for GDP growth in 2024 and 2025, and what are some of the biggest economic challenges facing China over this forecast horizon? Robin Xing: Well, we expect a modest growth recovery next year. Real GDP growth could edge up mildly from 4% two year kegger in 2023 to a slightly better 4.2% in 24. And the GDP deflator, which is a broader defined inflation indicator, it could rebound from a -.8% in this year, to .6% in 2024. But this is still way below a 2 to 3%, the level of inflation. So China will continue to grow and reflate at a subpar rate next year. The biggest challenge here is stabilizing the aggregate demand amid continued housing and the local government deleveraging. That requires more debt initially, particularly by the central government, to cushion this downturn. We expect a 1.5% point widening in China's government deficit next year. Led by a rising official budget and some increase in local special purpose bond. Monetary policy will likely remain accommodative as well. We expect a 25 basis point cut and the cumulatively another 20 basis points interest rate cuts in 2024. Now, Laura, turning it over to you. Over the past the year, the debate on investing in China has shifted profoundly towards long term structural challenges, we just discussed. And you have argued that this would continue into 2024. So what is your outlook for Chinese equities within the global EM framework over the next year? Laura Wang: We see a largely range bound market at best in our base case for China equity market at the index level. For example, our price target for MSCI China by end of 2024 is 60, suggesting very limited upside from its current level. Such upside puts China very much on par with what we expect from the broader emerging market index, MSCI EM. Therefore, we retain our equal weight rating on China within our EM API allocation framework. There will still be quite strong headwinds on corporate earnings as we go through the earnings results season for the rest of the year and then into the first quarter of 2024. This could lead to continuous downward revisions of consensus estimates. For example, we Morgan Stanley expect 9% earnings growth for MSCI China in 2024 compared to consensus at 16%, which we think is overly positive. Such downward revisions could also cap the valuation rerating opportunities. Robin Xing: Given this backdrop, Laura, how should investors be positioned in 2024 in terms of Chinese equities? Laura Wang: The Asia market, if we use CSI 300 as a proxy, has been outperforming the offshore MSCI China index for five years in a row. We expect this trend to continue at least in the next 3 to 6 months, given that the top down easing policies are starting to pivot to further support economic growth. And Robin, you are still expecting some easing on the monetary side with PSI rate cuts and the triple R cuts. Those usually tend to have a bigger impact on the Asia market than on the offshore space. Plus, I think we're also expecting some further currency weakness in the first half of next year and A-shares tend to be more resilient in such a scenario. Robin Xing: Finally, Laura, what is the market missing right now when it comes to Chinese equities? Laura Wang: As investors are still debating over the beta opportunities being largely absent for the past couple of years. We think some investors may easily come to the conclusion that there are not good investment opportunities in China anymore. We disagree with that. There are still plenty of alpha generating opportunities and particularly high quality names in the growth categories who can offer a strong earnings and ROE track record, good management teams and limited reliance on foreign technology input or on domestic government policy support. We believe those names can offer strong downside protection and help minimize your portfolio's volatility, while also offer the upside from their respective growing sectors when the market turns around. We have put together selected names that we believe meeting these criteria, and we call them the China best business model. Laura Wang: Robin, thanks a lot for taking the time to talk. Robin Xing: Great speaking with you, Laura. Laura Wang: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review on Apple Podcasts and share the podcast with a friend or colleague today.

Will India equities continue to outperform China equities in 2024? The two key factors investors should track.----- Transcript -----Welcome to Thoughts on the market. I'm Jonathan Garner, Morgan Stanley's Chief Asia and Emerging Market Equity Strategist. Along with my colleagues, bringing you a variety of perspectives, today I'm going to be discussing our continued preference for Indian equities versus China equities. It's Thursday, December 7th at 9 a.m. in Singapore. MSCI India is tracking towards a third straight year of outperformance of MSCI China, and India is currently our number one pick. Indeed, we're running our largest overweight at 100 basis points versus benchmark. In contrast, we reduced China back to equal weight in the summer of this year. So going into 2024, we're currently anticipating a fourth straight year of India outperformance versus China. Central to our bullish view on India versus China, is the trend in earnings. Starting in early 2021, MSCI India earnings per share in US dollar terms has grown by 61% versus a decline of 18% for MSCI China. As a result, Indian earnings have powered ahead on a relative basis, and this is the best period for India earnings relative to China in the modern history of the two equity markets. There are two fundamental factors underpinning this trend in India's favor, both of which we expect to continue to be present in 2024. The first is India's relative economic growth, particularly in nominal GDP terms. Our economists have written frequently in recent months on China's persistent 3D challenges, that is its battle with debt, deflation and demographics. And they're forecasting another subdued year of around 5% nominal GDP growth in 2024. In contrast, their thesis on India's decade suggests nominal GDP growth will be well into double digits as both aggregate demand and crucially supply move ahead on multiple fronts. The second factor is currency stability. Our FX team anticipate that for India, prudent macro management, particularly on the fiscal deficit, geopolitical dynamics and inward multinational investment, can lead to continued Rupee stability in real effective terms versus volatility in previous cycles. For the Chinese Yuan, in contrast, the real effective exchange rates has begun to slide lower as foreign direct investment flows have turned negative for the first time and domestic capital flight begins to pick up. Push backs we get on continuing to prefer India to China in 2024, are firstly around potential volatility of the Indian markets in an election year. But secondly, a bigger concern is relative valuations. Now, as always, we feel it's important to contextualize valuations versus return on equity and return on equity trajectory. Currently, India is trading a little over 3.7x price to book for around 15% ROE. This means it has one of the highest ROE's in emerging markets, but is the most expensive market. And in price to book terms, second only to the US globally. China is trading on a much lower price to book of 1.3x, but its ROE is 10% and indeed on an ROE adjusted basis, it's not particularly cheap versus other emerging markets such as Korea or South Africa. Importantly for India, we expect ROE to remain high as earnings compound going forward, and corporate leverage can build from current levels as nominal and real interest rates remain low to history. So the outlook is positive. But for China, the outlook is very different. And in a recent detailed piece, drawing on sector inputs from our bottom up colleagues, we concluded that whilst the base case would be for ROE stabilization, if reflation is successful, there's also a bear case for ROE to fall further to around 7% over the medium term, or less than half that of India today. Finally, within the two markets we're overweight India, financials, consumer discretionary and industrials. And these are sectors which typically do best in a strong underlying growth environment. They're the same sectors on which we're cautious in China. There our focus is on A-shares rather than large cap index names, and we like niche technology, hardware and clean energy plays which benefit from China's policy objectives. Thanks for listening. If you enjoyed the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

With China at risk of falling into a debt deflation loop, lessons from Japan's deflation journey could provide some insight.----- Transcript -----Daniel Blake: Welcome to Thoughts on the Market. I'm Daniel Blake from the Morgan Stanley Asia and Emerging Market Equity Strategy Team. Laura Wang: And I'm Laura Wang, Chief China Equity Strategist. Daniel Blake: And on this special episode of the podcast, we'll discuss what lessons Japan's deflation journey can offer for China. It's Thursday, October 26th at 10 a.m. in Singapore and Hong Kong. Daniel Blake: So in the period from 1991 to 2001, known as Japan's lost decade, Japan suffered through a prolonged economic stagnation and price deflation. While the corporate sector stopped deleveraging in the early 2000's. It wasn't until the Abenomics program, introduced under Prime Minister Shinzo Abe in 2013, that Japan emerged from deflation and started the process of a gradual recovery in corporate profitability. China's economic trajectory has been very different from Japan's over the last 30 years, but we now see some parallels emerging. Indeed, the risk of falling into a Japanese style stagnation is becoming more acute over the past year as a deep cyclical downturn in the property sector combines with the structural challenge that our economists call the 3D journey of debt, demographics and deflation. So, Laura, before we dig into the comparison between China and Japan's respective journeys to set the stage, can you give us a quick snapshot of where China's equity market is right now and what you expect for the rest of the year? Laura Wang: Sure, Daniel. China market has been through a quite volatile ten months so far this year with a very exciting start given the post COVID reopening. However, the strong macro momentum didn't sustain. Property sales is still falling somewhere between 30 to 50% each month on a year over year basis. And challenges from local government debt issue and early signs of deflationary pressure suggest that turn around for corporate earnings growth could still take longer to happen. We had downgraded China within the global emerging market context at the beginning of August, mainly out of these concerns, and we think more patience is needed at this point. We would like to see more meaningful easing measures to stimulate the demand and help reflate the economy, as well as clear a road map to address some of the structural issues, particularly around the local government debt problem. In contrast to China, Japan's equity market is very strong right now, and Morgan Stanley's outlook continues to be bullish from here. So, Daniel, why is it valuable to compare Japan's deflationary journey since the 1990s and China's recent challenges? What are some of the bigger similarities? Daniel Blake: I think we'll come back to the 3D's. So on the first to them, on debt we do have China's aggregate total debt around 290% of GDP. So that compares with Japan, which was about 265% of GDP back in 1990. So this is similar in the sense that we do have this aggregate debt burden sitting and needs to be managed. Secondly, on demographics, we've got a long expected but now very evident downturn in the share of the labor force that is in working age and an outright decline in working age population in China. And this is going to be a factor for many years ahead. China's birth rate or total number of births is looking to come down to around 8 million this year, compared with 28 million in 1990. And then a third would be deflation. And so we are seeing this broaden out in China, particularly the aggregate GDP level. So in Japan's case, that deflation was mainly around asset price bubbles. In China's case, we're seeing this more broadly with excess capacity in a number of industrial sectors, including new economy sectors. And then this one 4th D which is similar in both Japan's case and China now, and that's the globalization or de-risking of supply chains, as you prefer. When we're looking at this in Japan's case, Japan did face a more hostile trade environment in the late 1980s, particularly with protectionism coming through from the US. And we've seen that play out in the multipolar world for China. So a number of similarities which we can group under 4D's here. Laura Wang: And what are some of the key differences between Japan/China? Daniel Blake: So the first key difference is we think the asset price bubble was more extreme in Japan. Secondly, in China, most of the debt is held by local governments and state owned enterprises rather than the private corporate sector. And thirdly, China is at a lower stage of development than Japan in terms of per capita incomes and the potential for underlying growth. So, Laura, when you're looking ahead, what would you like to see from Chinese policymakers here, both in the near term as well as the longer term? Laura Wang: As far as what we can observe, Chinese policymakers has already started to roll out a suite of measures on the fronts of capital markets, monetary and fiscal policy side over the past 12 months. And we do expect more to come. Particularly on the capital market reform side, there are additional efforts that we think policymakers can help enforce. In our view, those actions could include capital market restructuring, funds flow and liquidity support, as well as further efforts encouraging enhancement of shareholder returns. To be more specific, for example, introducing more benchmark indices with a focus on corporate governance and shareholder returns, further tightening and enforcing the listing rules for public companies, m ore incentives for long term institutional participation, improving capital flow management for foreign investors, and implementing incentives to encourage dividend payouts and share buybacks. Those could all work quite well. Regulatory and even legislative support to help implement these measures would be extremely crucial. Daniel Blake: And what is your outlook for China's medium to long term return on equity path from here? And what are the key catalysts you're watching for that? Laura Wang: Given some of the structure challenges we discussed earlier, we do see a much wider forked path for China's long term growth ROE trajectory. We see MSCI China's long term ROE stabilizing at around 11% in the next 5 to 7 years in our base case. This means there should still be up to around two percentage point of recovery upside from the current levels, thanks to a combination of corporate self-help, the product cycle, policy support from the top and the low base effect. However, further upside above 11% will require a significant reflationary effort from the policymakers, both short term cyclical and long term structural, in combination with a more favorable geopolitical environment. Therefore, we believe prompt and forceful actions from policymakers to stabilize the economy to avoid more permanent negative impact on corporate and consumer behaviors are absolutely needed at this point. Now, let me turn this back to you, Daniel. What is your outlook for Japan's return on equity journey from here, and are there any risks to your bullish view? Daniel Blake: So we have seen Japan looking back from 2013 to now move from below book value in terms of aggregate valuations and a return on equity of just 4%, so much lower than even your bear case. So it's moved up from that level to 9% currently and we're seeing valuations moving up accordingly. We think that's further to go and we think Japan can actually reach 12% sustainable return on equity by 2025 and that's helped by return of nominal GDP growth in Japan and further implementation of governance improvements at the corporate level. So in terms of the risks, I think they are primarily external. We do see Japan's domestic economy in a pretty good place. We think BOJ can exit yield curve control and negative rates without a major shock. So externally we are watching China's risks of moving into a debt deflation loop, as we're discussing here, but also the potential impacts if the US or a global recession were to play out. So clearly we're watching very closely the Fed's efforts and global central bank efforts to achieve a soft landing here. Daniel Blake: So, Laura, thanks for taking the time to talk. Laura Wang: Sure. It's been great speaking with you, Daniel. Daniel Blake: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review on Apple Podcasts and share the podcast with a friend or colleague today.

Speaker: Mislav Matejka CFA, Head of Global Equity Strategy Despite some recent weakness, where SPX RSI turned technically oversold, we believe that the equity risk-reward remains challenging. Divergences between softer activity momentum and the elevated equity prices, as well as market internals, that opened up in the summer, are starting to close, but there is more to go. The PMI rebound that many were hoping for, the call that the weakness in manufacturing will end and join the more resilient services, remains elusive. In addition, real rates upmove is pressuring multiples, and this is even taking out Tech. Finally, Brent and USD rally should be seen as concerning for stocks. Most of Brent upmove is supply driven, and could lead to weaker final demand. Corporates might struggle to pass on rising input costs this time, in contrast to '21-'22. Historically, strengthening USD was almost always met with risk-off in equities. We do not think that bond yields will be able to keep moving up for too much longer, and will likely ultimately fall, and that is precisely because of the “higher for longer” narrative by the Fed. Q4 could end up a very good time to lock in the long duration trade for the next 12 months. SX5E had gone nowhere for half a year now, and has lagged the US since May, coincident with our downgrade to UW – stay short. Even as we remain bearish on China over the medium term, a lot has happened, MSCI China is down 20% since January, and one should not be tactically pressing the shorts into year end, in our view. We reiterate recent call to close the shorts on Miners, and we stay OW Energy.   This podcast was recorded on 01 October 2023. This communication is provided for information purposes only. Institutional clients can view the related report at http://www.jpmm.com/research/content/GPS-4524004-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.

Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy Month to date, in SXXP, Healthcare, Energy, Insurance, Staples and Utils are top sectors, a big change from earlier in the year, while the worst are Mining, Autos, Industrials, Travel & Leisure, Semis and Homebuilders. This reversal in leadership coincided with bond yields breaking out higher in August, from 4.0% to 4.30% for US 10 year. Can Defensives work if yields are going up, and should yields be going up in the first place? We think that bond yields' move is to a good extent driven by inflation forwards moving up, US debt downgrade, and demand-supply worsening, and not just due to forecasters abandoning their recession calls. If the above remain the dominant drivers, then it is unlikely that high-beta stocks will benefit from this; i.e., bond yields might be rising for the “wrong reasons”. MSCI China made new ytd lows last week, down 20%+ from Jan high. This usually mattered for the broader Cyclicals complex, and not just for Miners. Lastly, Eurozone PMIs are meaningfully down since May, coinciding with our downgrade to UW. As we feared, the positive convergence, which was the consensus call over the past 3-4 months by forecasters, is not coming through, PMIs appear to be converging to the downside. Our lead indicators continue to point to no meaningful recovery in the near term. Despite recent Cyclicals stalling, the gap between PMIs and market internals, which we highlighted in our July Chartbook, is still significant. We do not see bond yields moving higher from here, at least not for the right reasons, China is likely staying under pressure, and PMIs are weakening. Put together, we think that Cyclicals can show another leg lower.   This podcast was recorded on 28 August 2023. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4498704-0   for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.  

Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy Since the relative high in May to early last week, Eurozone has lost 12% vs the US, in USD terms, and is trying to bounce. We believe there is another leg of underperformance ahead, and reiterate our moving the region to UW two months ago. This was partly given our view that Eurozone activity momentum was about to roll over. Indeed, post the last two months of poor PMIs and other subdued data prints in Eurozone, its CESI is very weak currently, near the typical lows of the range. This could call for some short-term stabilization, but our view is that the Growth-Policy tradeoff in the region is likely to get worse through 2H. The gap between the performance of Eurozone/US equities and Value/Growth style has closed, but the next leg down could be driven by a move lower in bond yields, as well as the earnings disappointments coming up. Earnings and PMIs have a clear link, with downgrades likely at these levels of PMIs. What is at risk in Eurozone? The highest correlation with PMIs is usually seen among Autos and Banks. Banks could still have good numbers in Q2, as NII likely peaks towards the end of the year. We would use any strength on the back of positive results to reduce into. We stay cautious on Chemicals and Mining, despite an already meaningful chunk of underperformance. Capital Goods have been very strong in 1H, but could start to see weakness, as they typically trade with IP momentum. Finally, Semiconductors have near record inventory, many have been outperforming as a play on the AI theme, but the benefit is likely only marginal. The above outcome could be reinforced by any potential further disappointments in China. Now, as MSCI China was already down 20%+ from January highs to the recent low, the stimulus announcements, where the hopes are increasing, could result in bounces, but we advise using these pockets of strength to reduce further. The region is sliding back into deflation and the property market will likely need a much more aggressive policy support to rebound sustainably, given past excesses. This podcast was recorded on 20 October 2022. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4461310-0  for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2022 JPMorgan Chase & Co. All rights reserved.

Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy After a sharp ~60% rally during Nov-Jan, on the back of the reopening drive, MSCI China has lost 20% since. The latest China economic numbers, for April, have underwhelmed, including IP, retail sales and FAI. This is joining peaking PMIs, 20% lower iron ore price from highs, as well as a big slowdown in China CESI. The concern is weak confidence, which has restricted the broadening of recovery. The consumer might not get stronger, FAI and property are both structurally challenged, the external backdrop might not help and geopolitics could stay tough. Furthermore, our economic team does not anticipate any meaningful new stimulus measures for the rest of the year. Internal consumer mobility metrics have fully recovered, such as subway ridership and domestic flights. Unlike in the US and Europe, there might not be much pent up demand, as Chinese consumers didn't enjoy significant cash transfers during Covid lockdowns, and there are reports of wage cuts in certain industries. The property market has stabilized, post the sharp fall in activity, but new land sales are lower 30% ytd. The house prices are at risk of weakening. Tier 1 house prices in China are not dissimilar to what was observed in Japan in 1990, in terms of affordability. FAI and infrastructure spend could continue to lag, absent a fresh policy stimulus. FAI shares of GDP remain very high, compared to other countries. We believe that China exposure baskets might keep disappointing and more broadly we remain UW Value vs Growth style this year. China reopening was one of the big supports for Europe trade, where Eurozone beat the US by 30%+ since last September to most recently, in USD terms. The likely China rollover is one of the reasons why we decided to cut this trade earlier in the month. With this closure, we have the OWs on the following regions globally: Japan, UK and Switzerland. This podcast was recorded on 29 May 2023. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4425285-0  for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2022 JPMorgan Chase & Co. All rights reserved.  

Heute bei Aktien fürs Leben:Das Ganze sehen: Nach dem Absturz – wie geht es weiter mit Vonovia? (07:42) / Länderspiel: Alibaba (Aliexpress, Tmall...) spaltet sich in sechs Einheiten – lohnt sich der Kauf einzelner Aktien? (18:57) / Wahre Größe: Warum Johnson & Johnson viel mehr als der Corona-Impfstoff und die Penaten-Creme ist (32:08) //Über folgende Aktien wird gesprochen: Vonovia (WKN A1ML7J), Alibaba (WKN A2PVFU), Johnson & Johnson (WKN 853260), ishares MSCI China tech ETF (WKN A3CU00) +++60 Tage lang kostenlos Capital+ lesen – Zugriff auf alle digitalen Artikel, Inhalte aus dem Heft und das ePaper. Unter Capital.de/plus-gratis +++Keine Anlageberatung oder -empfehlung. Alle Angaben ohne Gewähr, diese stellen keinen Ersatz für eine professionelle und individuelle Beratung dar. Wertentwicklungen der Vergangenheit sind kein Indikator für zukünftige Wertentwicklung. +++Weitere Infos zu unseren Werbepartnern finden Sie hier: https://linktr.ee/aktienfuersleben +++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://datenschutz.ad-alliance.de/podcast.html +++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://art19.com/privacy. Die Datenschutzrichtlinien für Kalifornien sind unter https://art19.com/privacy#do-not-sell-my-info abrufbar.

Sailesh Jha, Group Chief Economist & Head of Market Research, RHB Banking discusses why the MSCI China is due for downside of 10-15% in 1H23.See omnystudio.com/listener for privacy information.

Speaker: Mislav Matejka, Head of Global Equity Strategy Some of the equity market supports that we were highlighting in Q4 – peaking bond yields, China reopening, lower European gas prices – are not exhausted, but a lot has repriced. SX5E is up 30% off the lows, and MSCI China up 55%. We argued that supportive seasonals at the start of the year and light positioning would still be helping as we move through Q1, but positioning is quickly normalizing. Sentiment was very downbeat 6 months ago; now investors are more comfortable chasing the market, with a bounce back towards neutral in Bull-Bear indicator, stretched RSIs, rebound in HF betas and a fall in Put/Call ratios. Crucially, we think the fundamental confirmation for the next leg of the rally will end up lacking, consequently Q1 will likely mark a high-water mark for the market. The cushion of consumer excess savings has been eroded, and money supply in the US and Europe keeps contracting. We held a view over the past two years that corporate earnings would be resilient, but this might start changing. Profit margins are at a record, currently much higher than pre-COVID-19, and pricing power is likely to deteriorate from here. Q1 results are coming out mixed, to date, with a sharply reduced proportion of beats, and the typical upward revisions that one sees as we move through reporting season so far are missing. Apart from likely renewed deterioration in fundamentals in 2H, potential curveballs could come from US politics, among other, as the market is now becoming complacent given that VIX is near the low of the range, at only 18x. International markets continue to screen as much more interesting than the US: stay long Europe vs SPX, keep OW FTSE100 and keep OW MSCI China. We were bullish Value vs Growth style last year, but this year look for stalling in Value, especially if our October call for peaking US yields keeps tracking. Finally, use the remaining Q1 rally to cut beta of a portfolio. This podcast was recorded on 05 February 2023. This communication is provided for information purposes only. Institutional clients can view the related report at www.jpmm.com/research/content/GPS-4325446-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.  

As investors have kept China's road to reopening top of mind, what comes after reopening and how might the Chinese economy and equity markets be impacted? Chief China Economist Robin Xing and Chief China Equity Strategist Laura Wang discuss.----- Transcript -----Laura Wang: Welcome to Thoughts on the Market. I'm Laura Wang, Morgan Stanley's Chief China Equity Strategist. Robin Xing: I'm Robin Xing, Morgan Stanley's Chief China Economist. Laura Wang: On this special episode of the podcast we'll discuss our 2023 outlook for China's economy and equity market, and what investors should focus on next year. It's Thursday, December 8th at 9 a.m. in Hong Kong. Laura Wang: So, Robin, China's reopening is a top most investor concern as we head into next year. You've had a long standing call that China will be reopening by spring of 2023. Is that still your view, given the recent COVID policy changes? Robin Xing: Yes, that's still our view. In fact, recent developments have strengthened our conviction on that reopening view. After several weeks of twists and turns following the initial relaxation on COVID management on November 10th, we think policymakers have made clear their intent to stay on the reopening path. We have seen larger cities, including Beijing, Guangzhou and Chongqing, all relaxed COVID restrictions in last week. We have seen the top policymakers confirmed shift in the country's COVID doctrine in public communication, and COVID Zero slogan is officially removed from any press conference or official document. They started the vaccination campaign, and last but not least, we have also see a clear focus on how to shift the public perception with a more balanced assessment of the virus. All of these enhanced our conviction of a spring reopening from China. Laura Wang: What are some of the key risks to this view? Robin Xing: Well, I think the key risk is the path towards a reopening. Before full reopening in the spring, China will try to flatten the curve in this winter. That is, to prevent hospital resources being overwhelmed, thus limiting access and mortality during the reopening process. This is because the vaccination ratio among the elderly remains low, with only 40% of people aged 80 plus have received the booster shot. Meanwhile, the medical resources in China are unevenly distributed between larger cities and the lower tier areas. As a result, we do expect some lingering measures during the initial phase of reopening. Restrictions that could still tighten dynamically in lower tier cities should hospitalizations surge, but we will likely see more incremental relaxation in large cities. So cases might rise to a high level, before a more nonlinear increase occurs after the spring full reopening. So this is our timeline of reopening, basically flattening the curve in the winter when the medical system is ready, to a proper full reopening in the spring. Laura Wang: That's wonderful. We are finally seeing some light at the end of the tunnel. With all of these moving parts, if China does indeed reopen on this expected timeline, what is your growth outlook for Chinese economy both near-term and longer term? Robin Xing: Well, given this reopening timeline, we expect that GDP growth in China to remain subpar in near term. The economy is likely to barely grow in the fourth quarter this year, corresponding to a 2.8% year over year. Growth were likely improved marginally in the spring, but still subpar as the continued fear of the virus on the part of the population will likely keep consumption at a subpar level up to early second quarter. But as normalization unfolds from the spring, the economy will rebound more meaningfully in the second half. Our full year forecast for the Chinese growth is around 5%, which is above market consensus, and that will be largely led by private consumption. We are expecting pent up demand to be unleashed once the economy is fully reopened by summertime. Robin Xing: So Laura, the macro backdrop we have been discussing have made for a volatile 2022 in the Chinese equity market. With widely anticipated policy shifts on the horizon, what is your outlook for Chinese equities within the global EM framework, both in near-term and the longer term? Laura Wang: This is actually perfect timing to discuss it as we have just upgraded Chinese equities to overweight within the global emerging market context, after staying relatively cautious for almost two years since January 2021. We now see multiple market influential factors improving at the same time, which is for the very first time in the last two years. Latest COVID policy pivot, as you just pointed out, and property market stabilization measures will help facilitate macro recovery and will also alleviate investors concerns about policy priority. Fed rate hikes cycle wrapping up will improve the liquidity environment, stronger Chinese yuan against U.S. dollar will also improve the attractiveness for Chinese assets. Meanwhile, we are also seeing encouraging signs on geopolitical tension front, as well as the regulatory reset completion front. Therefore, we believe China will start to outperform the broader emerging market again. We expect around 14% upside towards the end of the year with MSCI China Index. Robin Xing: How should investors be positioned in the year ahead and what effects do you think will be the biggest beneficiaries of China's reopening? Laura Wang: Two things to keep in mind. Number one, for the past three years, we've been overweight A-Shares versus offshore space, which had worked out extremely well with CSI 300 outperforming MSCI China by close to a 20% on the currency hedged basis over the last 12 months. We believe this is a nice opportunity for the relative performance to reverse given offshore's bigger exposure to reopening consumption, higher sensitivity to Chinese yuan strengthening and to the uplifting effect from the PCAOB positive result. Secondly, it is time to overweight consumer discretionary with focus on services and durables. Consumption recovery is on the way. Robin Xing: What are some of the biggest risks to your outlook for 2023, both positive and negative? Laura Wang: I would say the positive risks are more associated with earlier and faster reopening progress, whereas the negative risk would be more around higher fatality and bigger drag to economy, which means social uncertainty as well as bigger macro and earnings pressure will amount. And then geopolitical tension is also worth monitoring in the course of the next 12 to 24 months. Laura Wang: Robin, thanks for taking the time to talk. Robin Xing: Great speaking with you, Laura. Laura Wang: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review on Apple Podcasts and share the podcast with a friend or colleagues today.

Wer einen kommunistischen Überwachungsstaat für uninvestierbar hält, kriegt von der chinesischen Führung nahezu im Wochentakt neue Argumente geliefert. Sebastian Stöhr von Invesco hält im Gespräch mit Tobias Kramer und Christian W. Röhl dagegen – etwa mit dem MSCI China All Shares ETF, der Festland- und Offshore-Aktien in gleicher Weise abdeckt und damit breiter aufgestellt ist als der „normale“ MSCI China. Dazu gibt's Einblicke in chinesische Mid Caps, den hierzulande kaum bekannten Schnaps-Giganten Kweichow Moutai… und zum Schluss noch einen Abstecher nach Japan: Am Beispiel des JPX-Nikkei 400 ETF erklärt der Fonds-Profi die Funktionsweise und die Technik einer Währungssicherung.

In a special ad-hoc episode of the CIO Weekly Investment Outlook podcast, Stefanie Holtze-Jen, Chief Investment Officer in the Asia Pacific for Deutsche Bank's Private Bank, outlines her expectations of the 20th National Congress of the Chinese Communist Party (CCP) meeting's impact on markets. Whilst the meeting focused on the re-election of President Xi Jinping as party leader, with MSCI China falling nearly 30% this year to its lowest levels since mid-2009, valuations trading well below their 10-year median and following a realignment of governing priorities, bringing technological innovation and national security (in economic terms) to the forefront of policy for the next 5 years, Stefanie asks the question, “Is it time to re-evaluate Chinese equities in a balanced portfolio?”You can read our latest CIO Memo on China's recovery here: https://deutschewealth.com/content/dam/deutschewealth/cio-perspectives/cio-memo-assets/25-10-22/CIO-Memo-China-Recovery-continues-but-headwinds-are-growing.pdfFor more investing insights, please visit deutschewealth.comIn Europe, Middle East and Africa as well as in Asia Pacific this material is considered marketing material, but this is not the case in the U.S. No assurance can be given that any forecast or target can be achieved. Forecasts are based on assumptions, estimates, opinions and hypothetical models which may prove to be incorrect. Past performance is not indicative of future returns. Performance refers to a nominal value based on price gains/losses and does not take into account inflation. Inflation will have a negative impact on the purchasing power of this nominal monetary value. Depending on the current level of inflation, this may lead to a real loss in value, even if the nominal performance of the investment is positive. Investments come with risk. The value of an investment can fall as well as rise and you might not get back the amount originally invested at any point in time. Your capital may be at risk.The services described in this podcast are provided by Deutsche Bank AG or by its subsidiaries and/or affiliates in accordance with appropriate local legislation and regulation. Deutsche Bank AG is subject to comprehensive supervision by the European Central Bank (“ECB”), by Germany's Federal Financial Supervisory Authority (BaFin) and by Germany's central bank (“Deutsche Bundesbank”). Brokerage services in the United States are offered through Deutsche Bank Securities Inc., a broker-dealer and registered investment adviser, which conducts investment banking and securities activities in the United States. Deutsche Bank Securities Inc. is a member of FINRA, NYSE and SIPC. Lending and banking services in the United States are offered through Deutsche Bank Trust Company Americas, member FDIC, and other members of the Deutsche Bank Group. The products, services, information and/or materials referred to within this podcast may not be available for residents of certain jurisdictions. © 2022 Deutsche Bank AG and/or its subsidiaries. All rights reserved. This podcast may not be used, reproduced, copied or modified without the written consent of Deutsche Bank AG. 030620 030121

Wer in Emerging Markets investieren möchte, hat sich bestimmt schon einmal mit chinesischen Aktien auseinandergesetzt, denn die haben einen großen Anteil an Schwellenland-Indizes. Häufig gibt es Skepsis gegenüber dem chinesischen Aktienmarkt aufgrund der politischen Lage, außerdem gestaltet sich eine Investition aufgrund der vielen unterschiedlichen Aktienkategorien als sehr kompliziert. Doch China ist eine der größten Volkswirtschaften der Welt, weshalb man sich in jedem Fall Gedanken darüber machen sollte, ob und wie man chinesische Aktien im eigenen Portfolio aufnimmt. Deswegen schauen wir uns in dieser Folge an, welche Möglichkeiten es gibt, in den chinesischen Aktienmarkt zu investieren, welche Vor- und Nachteile es gibt und ob sich das Ganze lohnt.

Mit über 164 Mrd. Dollar Anlagevolumen ist der Nasdaq 100 ETF von Invesco der globale Standard für Tech-Investments. Doch neben dem legendären QQQ, der inzwischen zu 25% aus Apple und Microsoft besteht, hat der US-Vermögensverwalter noch einige andere Tech-ETFs im Sortiment. Etwa den Nasdaq Next Generation, sozusagen die 2. Liga der US-Wachstumsbörse. Oder den MSCI China Technology, über den man in diesen Zeiten ziemlich kontrovers diskutieren kann – genau wie über die Frage, was „Tech“ eigentlich ist und welches Potential spezielle Tech-Trends wie Blockchain noch haben. Das und einiges mehr jetzt im aktuellen echtgeld.tv-Talk mit Florian Förster. Und für alle, die lieber Dividenden- als Wachstums-Prozente sehen, gibt's auch noch was: Eine Einführung in „Preferred Shares“, die eben nicht das US-Pendant zu deutschen Vorzugsaktien sind.

Die USA und China sind die größten Volkswirtschaften der Welt. Noch haben die Vereinigten Staaten die Nase vorn. Wirtschaftsexperten zufolge wird China aber bereits 2028 die USA als größte Volkswirtschaft der Welt ablösen. Der Aufschwung Chinas als Wirtschaftsmacht hat Auswirkungen auf die globalen Finanzmärkte und damit auch auf dein Portfolio. Trotz dieses Strukturwandels sind die chinesischen Aktienmärkte in den globalen Aktienindizes noch immer unterrepräsentiert. Ein Grund: Der Finanzmarkt ist noch nicht vollständig für ausländische Anleger geöffnet. Wenn du nicht in einzelne chinesische Aktien investieren möchtest, sondern dein Vermögen breit gestreut auf viele Aktien verteilen willst, solltest du dich näher mit den Besonderheiten des chinesischen Aktienmarkts beschäftigen. In der heutigen Episode erfährst du, was es mit den Begriffen A-Aktien, H-Aktien oder Red-Chips auf sich hat und in welche ETFs du investieren solltest, um wirklich breit gestreut in chinesische Aktien investiert zu sein. Viel Spaß beim Anhören. ++ Tipp: Die extraETF App hat ein umfassendes Update erhalten. Ab sofort kannst du die App auch im Dark Mode nutzen. Verbinde zudem deine Wertpapierdepots und Robo-Advisors-Depots und erhalten einen umfassenden Einblick in dein Vermögen. Jetzt die extraETF App installieren. https://de.extraetf.com/service/extraetf-app ++ Informationen zu den im Podcast besprochenen Themen: Liste mit allen China-ETFs https://de.extraetf.com/etf-search?asset_class=2&land=45&strategy=null§or=null&sustainability=null Die 3 größten China-ETFs 1. iShares MSCI China A ETF https://de.extraetf.com/etf-profile/IE00BQT3WG13 2. Xtrackers CSI300 Swap ETF https://de.extraetf.com/etf-profile/LU0779800910 3. Xtrackers MSCI China ETF https://de.extraetf.com/etf-profile/LU0514695690 ETF-Vergleich A-Aktien vs. China alle Aktiensegmente https://de.extraetf.com/etf-comparison?etf=IE00BQT3WG13,LU0875160326,LU0514695690 ++++++++ Der perfekte Guide für deine Geldanlage mit ETFs https://de.extraetf.com/service/etf-guide Link zur neuesten Ausgabe des Extra-Magazins: https://shop.extraetf.com/collections/einzelausgaben?utm_source=podcast Hier kannst du ein Extra-Magazin abonnieren https://shop.extraetf.com/ Anmeldung für den extraETF Newsletter https://de.extraetf.com/service/etf-newsletter extraETF Finanzmanager: Überwache deine Portfolios https://de.extraetf.com/offer/overview extraETF App: Die beste App für ETF-Anleger https://de.extraetf.com/service/extraetf-app ++++++++ Wenn du dich noch intensiver über ETFs informieren möchtest, dann kann ich dir unsere Social-Media-Kanäle empfehlen. In unserer Facebook-Gruppe „ETF-Strategie by extraETF“ kannst du dich mit über 50.000 Anlegern über ETFs austauschen. Hier geht es zu Facebook-Gruppe. https://www.facebook.com/groups/173765373152193 Spannende Infos, News und Aktuelles rund um extraETF.com findest du auf unserem Instagram-Kanal. Wir freuen uns auf deinen Besuch! https://www.instagram.com/extraetf_de/ ++++++++ Es handelt sich dabei um einen Werbe- oder einen Affiliate-Link. Wenn du diesen Link klickst und etwas kaufst oder abschließt, erhalten wir eine Provision. Dir entstehen dadurch keine Mehrkosten. Vielen Dank für deine Unterstützung.

Carl Quintanilla and Jim Cramer began the hour by hitting the market action with stocks still on pace for their best month of the year. They also mentioned Treasury Secretary Janet Yellen telling NBC's Meet the Press over the weekend that “this is not an economy that's in recession.” The anchors then shifted their focus to the NFL, launching its own streaming service NFL+, which starts a $4.99 per month. Staying with media, they also mentioned SNAP getting double downgraded at Morgan Stanley from “overweight” to “underweight” with an $8 price target following last week's dismal earnings report. Also in focus: Goldman Sachs cut its earnings outlook for the MSCI China stock index to zero growth for the year.

SCBS 25/7/2565 : TLI to trade in SET today,risk for IRPC to be replace/ FOMC in spotlight; Powell's guidance for rate hike in Sep; GS cut MSCI China 2022 EPS to 0% growth on housing market; Food crisis likely peak out; 2Q22 Preview – BJC/ ERW (Raise TP to Bt4.20 from Bt4.0); Bank – 2Q22 recap (Add KTB as top pick)

SCBS 2/6/2565 : Today BTS BTSGIF Analyst meeting at 14.00/THANI Neutral,upgrade tp to Bt 4.90/ Digital Asset and Vietnam report*** # GS expects MSCI China earning to bottom out in 3Q22, but 2022 consensus forecast remain too optimistic and more downgrades are likely. # GS still OW China with a 20% upside for 12m basis, China is still trading at 15% below fair PE target, while the regulation cycle is turning. # THANI - Better loan growth and asset quality : THANI revised its 2022 loan drawdown target to at least Bt28-29bn (20-25%) from Bt26-27bn (12-15%) and loans outstanding to Bt54-55bn (9-11%). THANI is considering stepping back on adding management overlay provisions as NPL eased by -78bp to 3%. We raise 2022F loan growth to +10% (from +6%) and revise down 2022/23 credit cost by -5bp each to 0.95%. Thus we raise 2022/23F by +2%/+3% with earning recovery of +13%/+7%. Maintain Neutral TP raised to Bt4.9 (from Bt4.5).

The Chinese economy has grown tremendously over the past three decades, but its stock market has offered investors very dismal returns. Chinese stocks have had the worst performance among Asian and the world’s largest stock markets, according to the Morgan Stanley Capital International (MSCI) April data. Since its inception in December 1992, the MSCI China […]

Chief Asia and Emerging Markets Strategist Jonathan Garner highlights the key debates around his team's outlook on the region's growth, policy changes and more in the coming year.----- Transcript -----Welcome to Thoughts on the Market. I'm Jonathan Gardner, Chief Asia and Emerging Markets Equity Strategist for Morgan Stanley Research. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the 2022 outlook for Asia equities and some of the key debates for next year. It's Thursday, December the 2nd at 7:30am in Hong Kong. Since we published our year ahead outlook in mid-November, we've had the opportunity to debate the contents with clients in a number of formats, including presentations at our 20th Annual Asia Summit. So today I'd like to share that feedback and focus on some key debates. Our first debate is, why aren't we more bullish on Asia equities given our economics team's constructive view on 2022 global growth? The answer is that mapping GDP growth forecasts into company earnings growth forecasts is problematic since headline revenue growth is only one driver of earnings per share growth. Margins and leverage are also crucial, and even then, the sector breakdown of earnings growth in listed equities does not always match that of the economy as a whole. That said, broadly speaking, we are more constructive on Japan earnings growth than Emerging Markets and Asia earnings growth, given stronger relative gearing to the US, Europe and developed markets GDP growth, and the broad sector mix of export earnings and global cyclicals in Japan. We are anticipating earnings growth to continue next year and beyond consistent with continued global economic expansion. We expect 13% earnings per share growth from Tokyo's Stock Price Index “TOPIX" - in Yen - but only 8% for the MSCI Emerging Markets Index - in dollar terms. But it's fair to say that whilst we're in line with bottom-up consensus for TOPIX, we're around 500 basis points below consensus for emerging markets. And in aggregate, this has a lot to do with the macro headwinds of our house forecast of dollar strength for Emerging Markets, but also specific sectoral headwinds which we anticipate in areas like China Internet and Asia Semis and Tech hardware in Korea and Taiwan. Another key factor to consider is clearly what's in the price, and we think emerging markets, which are trading around 13x consensus forward P/E - or around the 60th percentile of the 5-year range - still have some downside to valuations over the next year as a whole, whilst we are comfortable with Japan valuations. Our second debate was, why we're not enthusiastic about buying back China equities. Here, we think risk/reward has not yet tilted definitively to the positive, particularly for offshore China growth stocks. We think earnings estimates still need to come down significantly further and similarly to Asia and emerging markets overall, valuations are not particularly cheap - at around 13x consensus forward price to earnings multiple for MSCI China. For sure, China's monetary policy is gradually changing to be more accommodative, and some measures have been taken to re-stimulate property sector demand. However, the Chinese economy has developed downward momentum over the summer and autumn and still faces significant downside risk this winter as a result of prior policy tightening and factors such as COVID Zero lockdowns on the consumer and the impact of regulatory reset on private sector capital spending. Our proprietary indicator of Global Multinational Corporations' sentiment, vis-a-vis their Chinese operations, has just reported its biggest ever quarterly decline and is now at the second lowest since we began our regular quarterly survey. The third debate was, why are we constructive on emerging markets energy? Our answer is that the energy sector and energy sensitive markets are typically later cycle performers, and early next year will mark the second anniversary of the short but intense COVID-driven recession, which at one point marked the first time ever that oil prices went negative. We've come a long way since then in terms of demand recovery, but more is likely still to come if our commodities team is right that Brent can trade over $90 a barrel in 2022. This is the payback for underinvestment in conventional energy supply in recent years, mainly due to ESG concerns. So, it's an example of where our house view on strong global growth in 2022 and 2023 does lead directly to an investment conclusion for a particular sector. And MSCI EM Energy is trading at book value versus 1.9x price to book for the index, and with a free cash flow yield of almost 9%. Before I close, there is a lot of discussion around the new COVID 19 variant, Omicron, and whether it changes our views. At present, we're in early days on this variant and as such, it doesn't change our already cautious view on the outlook for Asia equities. Thanks for listening. If you enjoy the show, please leave us a review on Apple Podcasts and share Thoughts on the Market with a friend or colleague today.

Precisamos falar sobre XINA11! Você sabe por que o ETF XINA11 tem caído tanto? No Cafeína de hoje, entenda melhor sobre a política chinesa e como ela afeta os ativos chineses. Desde o ano passado que novas modalidades de investimento ficarem acessíveis ao pequeno investidor. Sendo assim, foi possível investir em países que antes apenas abrindo uma conta no exterior daria para acessar. Um exemplo foi o XINA11, um ETF que replica o MSCI China - índice composto por 800 empresas chinesas. Mas desde seu lançamento na B3, ele acumula uma queda de cerca de 12%. A questão é que tanto as bolsas chinesas como as de Hong Kong vêm acumulando quedas. E fica a pergunta: por quê? #CAFEINAINVESTNEWS FECHAMENTO DO MERCADO (16/08/21) O Ibovespa caiu 1,66%, aos 119.180 pontos. O dólar subiu 0,65%, a R$ 5,27.

THE OPPORTUNITY - “ถึงเวลา Tactical Call หุ้นเทคฯ จีน คู่ MSCI China พร้อมมุมมองหุ้นไทยและอินเดีย” ดูแบบมีภาพได้ที่ : https://youtu.be/DvzvsMmQ5sw

ETF significa (Exchange-Traded Fund) ou em português (Fundos Negociados em Bolsa), nada mais é que um fundo de investimento que replica o comportamento de índices, comprando ações e atualizando na mesma proporção e atualizando a medida que esses índices são alterados; •Outra característica, é que suas cotas são negociadas no pregão da bolsa de valores como se fossem ações, diferente de fundos de investimentos comuns; •ETFs são muito conhecidos e desenvolvidos no exterior. No Brasil, foi regulamentado em 2002, mas apenas mais recentemente passou a ganhar mais relevância na carteira dos investidores; • Referenciados em índices como Ibovespa, Índice de Governança Corporativa (IGC), Índice de Sustentabilidade Empresarial (ISE), Índice de Dividendos (IDIV) e até S&P 500, um dos principais índices do mercado americano de ações; •Existem ETFs que têm como base índices de renda fixa, como o IMA-B (que acompanha o desempenho de títulos públicos atrelados à inflação); •A cada ano, o volume de negociações com ETFs aumenta. Em 2018, a média diária foi de R$ 432 milhões. Aumentou para R$ 780 milhões em 2019 e para R$ 1,5 bilhão nos dois primeiros meses de 2020; •No mercado global de ETFs, há uma variedade grande de tipos diferentes de ETF. São muito conhecidos os fundos de índices de ações, e só nesse grupo já existem muitas opções: ETFs de índices amplos, segmentados, setoriais, nacionais ou internacionais. Mas há também fundos de outros tipos de índices, como ETFs de moedas, de commodities ou de papéis de renda fixa; • Quais vantagens e desvantagens? • Para investidores novos e pequenos, a vantagem é que investindo em um ETF, ele estará investindo em várias empresas ao mesmo tempo, sem precisar analisar uma a uma, já que um fundo administrador está fazendo isso por ele; • Maior diversificação. Por ser um pacote de ações o investimento conta com maior diversificação em número de ativos e segmentos de mercado; •No mercado fracionário, com apenas R$ 1.000 um investidor jamais conseguiria diversificar da mesma forma que um ETF consegue, por ser um pacote de ações; •Menor volatilidade graças a diversificação; •Portanto com um ETF que replica um índice, você tem a garantia que irá performar ao menos igual a média do mercado; •A taxa de administração de um ETF é baixa, o que é uma vantagem quando comparada a de alguns fundos de investimentos. •A desvantagem é que a oferta e a variedade no Brasil é baixíssima, comparado a outras países; • Investir em ETF's no exterior é muito melhor pela gama de oferta se bem diversificada é maior; •ETF's não pagam dividendos, eles reinvestem seus dividendos em novas cotas; •Sem isenção de IR na venda, isso não existe. Nos ETF's qualquer venda COM LUCRO, você terá de apurar este lucro e gerar uma DARF e fazer o recolhimento de imposto devido; •Principais ETF's brasileiros: BOVA11 (índice Bovespa), IVVB11 (índice S&P 500), IMAB11 (títulos IPCA do Tesouro Direto) e SMLL11 (índice SMALL CAPS brasileiras), XINA11 (índice MSCI China) e EURP11 (índice MSCI Europe); •O fundo de investimento é um mecanismo que reúne o dinheiro de diversas pessoas (chamadas de cotistas) com o objetivo contratar um gestor para cuidar do dinheiro ali investido; •O objetivo final dos cotistas é obter ganhos a partir da aplicação no mercado financeiro; •Ao comprar cotas de um determinado fundo, o cotista aceita suas regras de funcionamento (aplicação, resgate, horários, custos, etc), e passa a pagar uma taxa de administração para que um administrador coordene o funcionamento do fundo; •Credenciados pela CVM, eles acompanham diariamente os recursos do fundo, avaliando as opções existentes, cenários, acontecimentos políticos e econômicos, e possuem poderes para tomar decisões de investimento para você; •O fundo em si é isento de Imposto de Renda sobre os ganhos que acumula, ou seja, o fundo não recolhe IR quando vende um ativo para comprar outro. Siga nas redes @rafa.brazao e @andersonnascimento.01

With growing interest in investing in China in recent years - what has it been like to invest in Chinese equities for two decades? In this episode I spoke with Baijing Yu, manager of the Comgest Growth China fund, which is celebrating its 20 year anniversary. Since inception in 2001 the fund has returned 69.4% compared with the MSCI China's return of 66.5%.

ดัชนี MSCI China ปรับลดลงมาแล้ว 20% นับจากเดือนกุมภาพันธ์ที่ผ่านมา ตลาดหุ้นจีนจะยังน่าสนใจหรือไม่ หรือเป็นจังหวะให้ลงทุน พูดคุยกับ รัฐศรัณย์ ธนไพศาลกิจ หัวหน้าฝ่ายหลักทรัพย์ต่างประเทศและฟิวเจอร์ส บล.บัวหลวง เกาะติดกำไรบริษัทจดทะเบียน (บจ.) ไตรมาสแรก หลังจากที่ผลประกอบการไตรมาส 1 ปี 2564 ออกมาดีกว่าที่นักวิเคราะห์คาดการณ์ไว้ หุ้นกลุ่มไหนมีแนวโน้มกำไรดี และจะมีความเสี่ยงใดที่ต้องเผชิญจากการแพร่ระบาดระลอกสาม นักวิเคราะห์ประเมินสถานการณ์นี้อย่างไร

ดัชนี MSCI China ปรับลดลงมาแล้ว 20% นับจากเดือนกุมภาพันธ์ที่ผ่านมา ตลาดหุ้นจีนจะยังน่าสนใจหรือไม่ หรือเป็นจังหวะให้ลงทุน พูดคุยกับ รัฐศรัณย์ ธนไพศาลกิจ หัวหน้าฝ่ายหลักทรัพย์ต่างประเทศและฟิวเจอร์ส บล.บัวหลวง เกาะติดกำไรบริษัทจดทะเบียน (บจ.) ไตรมาสแรก หลังจากที่ผลประกอบการไตรมาส 1 ปี 2564 ออกมาดีกว่าที่นักวิเคราะห์คาดการณ์ไว้ หุ้นกลุ่มไหนมีแนวโน้มกำไรดี และจะมีความเสี่ยงใดที่ต้องเผชิญจากการแพร่ระบาดระลอกสาม นักวิเคราะห์ประเมินสถานการณ์นี้อย่างไร

I've been avoiding talking about endowment policies, because what even are they? I haven't come across one in my own investment life. This week, a question from Sandile sent me down the endowment road. I had fun with it. I got the Tax Elves involved. They had fun with it. Fun was had by all. Endowments are the love child of insurance and investments. They have a five-year lock-in period, a tax rate of 30%, a life assured and a beneficiary. If you are in a higher tax bracket and looking for a long-term investment vehicle, endowments are worth investigating. They can also play a role in estate planning. It pays out directly to the beneficiary, which is great if you are leaving someone behind who is financially dependent on you. As De Wet de Villiers pointed out, the fact that they pay out tax-free doesn't mean they're not taxed in the estate. It simply means the estate is liable for the tax, not the beneficiary.  In addition to teaching me a thing or two about endowments, Sandile's question could serve as a template if you're hoping to add new holdings to your portfolio. His clear reasoning and systematic approach to adding this investment is worthy of emulation. Subscribe to our RSS feed here. Subscribe or rate us in iTunes. Win of the week: Pru I've tried to break up with my advisor for the last year, but it has been difficult! Everytime I say to him, we need to talk and I want to move my investments, he takes me out on a nice date, listens to me and then goes on to scare me into staying with him. He tells me EasyEquities is not the right platform for me and I should be careful of companies like 10X. It does not help that he also butters me up and tells me how great I am, while also telling me about his life, so I end up feeling I can't leave him because he confides in me. My people-pleasing self feels bad for wanting to break up with him. It's the perfect emotionally manipulative relationship and I JUST CAN'T LEAVE!  How does one amicably break up with their financial advisor? More importantly, how do you leave them when you have a fear of managing your money independently?  I have listened to your podcast, and some episodes more than once. I read Sam Beckbessinger's book and Vicki Robin's book called Your Money or Your Life. I aspire to be a Patrick Mckay and I have a financial strategy to reach FIRE, but my greatest hurdle is letting my financial advisor go and trusting myself that I can manage my investments myself.  When he is not around I feel as though I can manage my money independently and I do not need him, but after meeting with him, I leave with a great sense of fear about moving my TFSA from Sanlam to Easy and moving my RA from Discovery to TenEx or Outvest. All the financial aspects that do not involve him I have managed relatively well, like my emergency fund. I know I can manage my money, I just fear that if I move my investments to the "big bad world of ETFs" (which is how he makes it sound), I will lose everything! I know he may be playing Jedi mind tricks on me, but how do I stop myself from being tricked! Also, he is not a bad person, he is a very nice guy, but I think this is part of my problem, I am making this whole relationship too personal! I feel defeated!  Sandile I stumbled on this product by Sygnia where you can get direct exposure to Berkshire Hathaway.   Here is why I'm looking into buying into this fund: I believe that Berkshire is going to have ample opportunity to buy really decent businesses at decent prices as Covid continues to decimate some much needed industries.  I believe Berkshire is one of those great businesses that one can buy at a decent price, thanks to Covid; I bought a few units in late Jan through EasyEquities and the costs to transfer funds and transact in USD was rather hefty, so I think I'll leave that to a local fund to handle that; I have looked at the S&P500 (which I hold) and in my view, the Berkshire allocation there is rather small and I'd like more exposure; Sygnia offers this fund for “discretionary savings into a 5-year endowment, a retirement annuity or a living annuity”. I would like to avoid setting up an RA with yet another service provider at the moment and I have no need for a living annuity, which leaves me with the endowment fund option. From the little that I could read up on endowment funds: I am fairly comfortable with the idea of leaving the cash invested for at least five years (if not more); My marginal income tax rate exceeds 41% so at 30% tax, the fund is saving me some element of tax; I have set up an emergency fund (around 6 months' salary) so I think the risk of cancelling the endowment before 5 years is low; TFSA has been maxed for 2021 year of assessment. I contribute far less than the allowed 27.5% into my RA (I am busy assessing contributing into an RA vs increasing my employer-pension fund contributions); I am just uncertain if I'm opening myself up to more unknown risks/complications/costs by using this structure. Kimberley  I am a shareholder for a company who has moved operations to Mauritius. If our company is lucky enough to declare dividends, this will now be paid in USD.  How does this affect my tax?   Is there a way I can get it in ZAR without losing so much to tax or is it better I keep it offshore ?  I like the idea of keeping it offshore for emergencies or as a “life insurance” for me when I pass away to leave to my daughter. Is this possible with only holding a SA passport?   Perhaps I could open an offshore trust and list her as the beneficiary and the dividends get paid into that?  Could I open a USD trading account on EE and get the dividends paid directly to that?  Is what I'm wanting to do by not bringing it into SA even legal?     I feel there are not enough bubbles, chuckles, coffee and chai tea to get me through the questions I have and the changes I need to implement to get my financial ducks in a row.  Right now these ducks have ADHD and when they seem to be in a row, they decide to go off on a fucking tangent.   Anton  I inherited a farm in 1994 and sold it in 2019. I have the value of it when I got it and when I sold it. I did not get a valuation in 2001 when CGT started. I would like to know how to work out the CGT on this transaction.  Download the calculator here.   Moore I am 27 and have a pension/provident plan with my employer. I would like to have an RA for a top up. I would also like to invest in shares. I don't know how to go about doing any of those. I have an EasyEquities account but I don't really know which shares to target, and for which amount every month. I have a R1000 that I can divide for those two financial goals. With that amount of money and my age, I am not even sure if that will be enough to contribute. I've only been exposed recently to this saving and investing movement. I was so ignorant.  Thanks to the Fat wallet Community on Facebook I have managed to put some savings for Emergencies with Tyme bank. Catherine I've tried the Interactive Brokers demo account and find it a little intimidating. I don't know what options or margins are, and I don't want to enact them by mistake by clicking the wrong button. I also imagine their customer service is not catered for noobs like me. Having said that, the platform is becoming less intimidating the more I play with the demo account. Another option is to buy the shares through a Standard Bank Webtrader account, which has broker fees of 0.345% and annual account fees of 0.26%, and then transfer the amount across to my EasyEquities USD account to avoid paying ongoing annual fees. Do you have any thoughts on each of these options, considering that my goal is to pay the lowest fees possible over the next 20 years, but also have a relatively user-friendly experience.  I don't have a credit card. The only time this has ever been a problem is when a hotel or car rental company requires a credit card for a booking or deposit. It is pretty frustrating being at an airport and unable to rent a car. And are there any ways to get around this booking/deposit problem without having a credit card? And do you know of any reasons to have a credit card aside from this (assuming I don't need the credit)? Are credit cards generally better than debit cards for general spending while travelling? Melisha I have two kids in grade 4 and grade 0. I usually save up the school fee money to pay once off and get a 5% discount in December of the previous year. I anticipate a 10% increase in school fees. So essentially I need to save R20k a month for both kids' school fees for the 2021 school year. We usually put the money into a savings account but now the interest rates are so low. At the moment the money is in a Tyme bank account goal save but i was wondering if there was something better out there? Something with low risk, short term and potentially to beat money market type accounts.  Our friend Walter made a site called Rate Compare https://www.ratecompare.co.za/.  Tristan Lately I have been seeing ads on YouTube for a financial service app called Franc. It has 4 stars on the Google Play Store but I was wondering if you had heard of it, seen it or tried it? Lastly, can we trust Franc? Ken  What is all the hype over Mexem Africa about? I have gone to their website but, quite frankly, it looks like a scamsters website (although I thought the same about Easy Equities' website too, before I started using it).  I don't see any info on tax free accounts, and they mention all sorts of foreign currencies but not much about how you convert your rands to Dollars/Euros/etc...  The little section on fees is as clear as mud.  As an ETF investor (tax free and discretionary) should I be looking into it in a bit more detail? Would really appreciate a chat between you and Simon on this. Brian I've been with etfSA since 2012. I am busy updating my etf portfolio and want to know if I should shift some funds or all to Easy Equities. I've already bought MSCI China through my Easy Equities account that I registered a few weeks ago. What is your suggestion?